NewGenIvf announced that its wholly owned subsidiary, First Fertility PGS Center, has launched a strategic expansion initiative targeting the Indian medical tourism market for fertility treatments. This initiative positions NewGen to capitalize on Thailand’s rapidly growing fertility tourism sector, which has emerged as a preferred destination for international patients seeking advanced reproductive care. Thailand’s strategic advantages as a medical tourism destination continue to drive sector growth, supported by the country’s advanced healthcare infrastructure, progressive regulatory environment, and supportive tourism policies that include visa-free entry for Indian nationals. First Fertility leverages these national advantages while addressing the specific gap in culturally tailored fertility care for Indian patients, who represent a significant and underserved segment of the regional medical tourism market.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NIVF:
- NewGenIvf introduces NewGenSort to support men’s reproductive health in Asia
- NewGenIvf Group Ltd trading halted, news pending
- NewGenIvf Group announces 1 for 10 reverse stock split
- NewGenIvf Group Announces Reverse Stock Split Effective May 5, 2025
- NewGenIvf Group reports FY24 EPS (64c) vs. $3.53 last year